BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 21688534)

  • 1. [Effects of Bushen qiangdu decoction on MMP-9 and TIMP-1 produced by peripheral blood mononuclear cells in patients with ankylosing spondylitis].
    Zhang YZ; Yan XP; Ye LY; Zhang WJ; Lou JN
    Zhongguo Gu Shang; 2011 May; 24(5):387-91. PubMed ID: 21688534
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of matrix metalloproteinases-9 and tissue inhibitor of metalloproteinaes-1 in chronic obstructive pulmonary disease].
    Xu XM; Sun TY; Lin JB; Zhang HS
    Zhonghua Yi Xue Za Zhi; 2003 Jul; 83(13):1138-41. PubMed ID: 12921631
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-18 initiates release of matrix metalloproteinase-9 from peripheral blood mononuclear cells without affecting tissue inhibitor of matrix metalloproteinases-1: suppression by TNF alpha blockage and modulation by IL-10.
    Nold M; Goede A; Eberhardt W; Pfeilschifter J; Mühl H
    Naunyn Schmiedebergs Arch Pharmacol; 2003 Jan; 367(1):68-75. PubMed ID: 12616343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 15 stimulates production of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 by human peripheral blood mononuclear cells.
    Constantinescu CS; Grygar C; Kappos L; Leppert D
    Cytokine; 2001 Feb; 13(4):244-7. PubMed ID: 11237433
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: effects of LDL-apheresis.
    Nenseter MS; Narverud I; Græsdal A; Bogsrud MP; Halvorsen B; Ose L; Aukrust P; Holven KB
    Cytokine; 2013 Jan; 61(1):194-8. PubMed ID: 23131422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
    Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
    Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of metalloproteinase-2, metalloproteinase-9, and tissue inhibitor of metalloproteinase-1 in transitional cell carcinoma of upper urinary tract: correlation with tumor stage and survival.
    Miyata Y; Kanda S; Nomata K; Hayashida Y; Kanetake H
    Urology; 2004 Mar; 63(3):602-8. PubMed ID: 15028476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of matrix metalloproteinase-9 and tissue inhibitor-1 of metalloproteinase expression on atrial structural remodeling during chronic atrial fibrillation].
    Zhu H; Zhang W; Guo CH; Zhang G; Zhang WD; Zhong M; Yang GR; Ge ZM; Zhang Y
    Zhonghua Yi Xue Za Zhi; 2005 Jan; 85(1):45-8. PubMed ID: 15808077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity.
    Chen CH; Lin KC; Yu DT; Yang C; Huang F; Chen HA; Liang TH; Liao HT; Tsai CY; Wei JC; Chou CT
    Rheumatology (Oxford); 2006 Apr; 45(4):414-20. PubMed ID: 16287916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Matrix metalloproteinase production by bone marrow mononuclear cells from normal individuals and patients with acute and chronic myeloid leukemia or myelodysplastic syndromes.
    Ries C; Loher F; Zang C; Ismair MG; Petrides PE
    Clin Cancer Res; 1999 May; 5(5):1115-24. PubMed ID: 10353746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of the sera of rabbits fed with Tongxinluo on MMP-9 and TIMP-1 expression and secretion in U937 monocyte-derived macrophages].
    Liu JL; Zhu QF; Hao BS
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1703-6. PubMed ID: 18819903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Expression of MMP-2, MMP-9 and TIMP-1 and the effects of methylprednisolone in EAM].
    Zhang N; Xiao B; Li J
    Hunan Yi Ke Da Xue Xue Bao; 2003 Feb; 28(1):5-8. PubMed ID: 12934382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of matrix metalloproteinase (MMP) and tissue inhibitor of MMP (TIMP) genes in blasts of infant acute lymphoblastic leukemia with organ involvement.
    Suminoe A; Matsuzaki A; Hattori H; Koga Y; Ishii E; Hara T
    Leuk Res; 2007 Oct; 31(10):1437-40. PubMed ID: 17350093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metalloproteinases and their tissue inhibitors in multiple sclerosis.
    Ozenci V; Rinaldi L; Teleshova N; Matusevicius D; Kivisäkk P; Kouwenhoven M; Link H
    J Autoimmun; 1999 Jun; 12(4):297-303. PubMed ID: 10330301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
    Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relation of matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 ratio in peripheral circulating CD14+ monocytes to progression of coronary artery disease.
    Brunner S; Kim JO; Methe H
    Am J Cardiol; 2010 Feb; 105(4):429-34. PubMed ID: 20152234
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired inhibitory effect of interleukin-10 on the balance between matrix metalloproteinase-9 and its inhibitor in mononuclear cells from hyperhomocysteinemic subjects.
    Holven KB; Halvorsen B; Bjerkeli V; Damås JK; Retterstøl K; Mørkrid L; Ose L; Aukrust P; Nenseter MS
    Stroke; 2006 Jul; 37(7):1731-6. PubMed ID: 16728689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Expression of matrix metalloproteinases-9 and tissue inhibitors of matrix metalloproteinases-1 in connective tissue of vaginal wall of women with stress urinary incontinence].
    Zhang QF; Song YF; Zhu ZY
    Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):810-3. PubMed ID: 17327109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased acinar damage of salivary glands of patients with Sjögren's syndrome is paralleled by simultaneous imbalance of matrix metalloproteinase 3/tissue inhibitor of metalloproteinases 1 and matrix metalloproteinase 9/tissue inhibitor of metalloproteinases 1 ratios.
    Pérez P; Kwon YJ; Alliende C; Leyton L; Aguilera S; Molina C; Labra C; Julio M; Leyton C; González MJ
    Arthritis Rheum; 2005 Sep; 52(9):2751-60. PubMed ID: 16142742
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.